How much revenue does Applied Biosciences make?

Applied Biosciences reported $707,062 in revenue for fiscal year 2019, up 257.9% from $197,554 in fiscal year 2018. In Q3 2020 revenue was $169,575.

What companies are similar to Applied Biosciences?

Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include TetraLogic Pharmaceuticals Corporation (TLOG), OncoVista Innovative Therapies, Inc. (OVIT), Khiron Life Sciences Corp. (KHRNF), Millennium Investment & Acquisition Company Inc. (MILC).

Applied Biosciences Corp. (APPB) Stock

About Applied Biosciences Corp.

Applied Biosciences Corp. focuses on the development and commercialization of synthetic cannabinoid therapeutics/biopharmaceuticals that target the endocannabinoid system to treat a range of diseases across various therapeutic areas. It delivers consumer and OTC THC-free CBD products that promote overall health and wellbeing, as well as testing and analytics capabilities to its customers. The comp...

At a glance

Applied Biosciences reported revenue of $707,062 for fiscal year 2019, up 257.9% from fiscal year 2018, and net income of -$2.63 million. In Q3 2020 (the quarter ended December 31, 2019) revenue was $169,575, down 59.0% from a year before.

Figures from company filings; latest fiscal year ended March 31, 2019.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.